Codes ATC:
N05CD08
EMLc
Indication
Palliative care
Code ICD11:
QC7A
INN
Midazolam
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Liquid:
2 mg per mL
(EMLc)
Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial ; 5 mg per mL in 1 mL vial ; 5 mg per mL in 3 mL vial
Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Oral > Solid > dosage form: 7.5 mg (EML) ; 15 mg (EML)
Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial ; 5 mg per mL in 1 mL vial ; 5 mg per mL in 3 mL vial
Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration) ; 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration) ; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Oral > Solid > dosage form: 7.5 mg (EML) ; 15 mg (EML)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of midazolam solution for oral administration 5 mg/mL and 10 mg/mL to the EML and EMLc;
- the deletion of midazolam solid oral dosage forms from the EMLc;
- to modify the formulations descriptions of midazolam injection to better describe the available dosage forms.